Business
Perimeter Medical Imaging AI Announces LIFE Financing and Concurrent Private Placement
Perimeter Medical Imaging AI Announces LIFE Financing and Concurrent Private Placement Ca...

About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n\n\nPerimeter Medical Imaging AI Announces LIFE Financing and Concurrent Private Placement\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nCanada NewsWire\n\n\n /NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES/TORONTO and DALLAS, April 21, 2026 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (\"Perimeter\" or the \"Company\"), a commercial-stage medical technology company, is pleased to announce that it has entered into an agreement with Paradigm Capital Inc., as lead agent and sole bookrunner on behalf of a syndicate of agents (collectively, the \"Agents\"), in connection with a \"best efforts\" offering under the listed issuer financing exemption (the \"LIFE Offering\") of up to 21,489,000 units of the Company (the \"Units\"), at an offering price of $0.35 per Unit, for aggregate gross proceeds of up to approximately $7.52 million, subject to a minimum offering amount of approximately $5.55 million (the \"Minimum LIFE Amount\"). The Company also intends to complete a concurrent non-brokered private placement of convertible debentures (the \"Convertible Debentures\"), for aggregate gross proceeds of up to approximately USD$5 million (the \"Concurrent Offering\" and, together with the LIFE Offering, the \"Offerings\").Each Unit will be comprised of one common share in the capital of the Company (each a \"Common Share\") and one Common Share purchase warrant (each, a \"Warrant\"). Each Warrant shall entitle the holder to acquire one Common Share for a period of 60 months from the closing of the LIFE Offering, at an exercise price of $0.50. In connection with the Concurrent Offering, the Company has entered into binding subscription agreements with Adrian Mendes, its Chief Executive Officer, and SC Master Holdings LLC (\"Social Capital\"), representing expected subscription proceeds totaling approximately $5.5 million.Under the Concurrent Offering, each Convertible Debenture will consist of $1,000 principal amount of 3.59% convertible debentures of the Com...